EFFECTS OF TCV-116 AND CV-11974 ON ANGIOTENSIN-II-INDUCED RESPONSES IN VASCULAR SMOOTH-MUSCLE CELLS

被引:12
作者
FLESCH, M [1 ]
KO, Y [1 ]
SEUL, C [1 ]
DUSING, R [1 ]
FELTKAMP, H [1 ]
VETTER, H [1 ]
SACHINIDIS, A [1 ]
机构
[1] UNIV BONN, MED POLIKLIN, D-53111 BONN, GERMANY
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1995年 / 289卷 / 02期
关键词
CV-11974; TCV-116; SMOOTH MUSCLE CELL; VASCULAR; CELL GROWTH; C-FOS;
D O I
10.1016/0922-4106(95)90121-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
(+/-)-1-(Cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116, Candesartan) and its active metabolite 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974) are specific nonpeptide angiotensin AT(1) receptor antagonists. In the present study, the inhibitory potency of these two antagonists on the angiotensin II-induced responses in aortic vascular smooth muscle cells from Wystar Kyoto rats was investigated. The specific binding of I-125-angiotensin II to cells was inhibited by CV-11974 and TCV-116 with a half-maximal inhibitory concentration (IC50) of 3 x 10(-11) M and 1 x 10(-9) M, respectively. CV-11974 and TCV-116 inhibited the angiotensin II-induced increase in [H-3]thymidine incorporation with an IC50 of 3 x 10(-10) and 5 x 10(-9) M, respectively. Both CV-11974 and TCV-116 (10(-7) M) completely blocked the angiotensin II-induced increase in c-fas mRNA. The inhibitory potency of the metabolite CV-11974 was about 30-100-fold higher than that of the prodrug TCV-116.
引用
收藏
页码:399 / 402
页数:4
相关论文
共 15 条
[1]  
CHAMLEY JH, 1979, PHYSIOL REV, V39, P1
[2]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[3]  
CHIU AT, 1990, J PHARMACOL EXP THER, V252, P711
[4]   BIOCHEMICAL-CHARACTERIZATION OF 2 ANGIOTENSIN-II RECEPTOR SUBTYPES IN THE RAT [J].
DEGASPARO, M ;
WHITEBREAD, S ;
MELE, M ;
MOTANI, AS ;
WHITCOMBE, PJ ;
RAMJOUE, HP ;
KAMBER, B .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 16 :S31-S35
[5]   LOSARTAN INHIBITS THE ANGIOTENSIN II-INDUCED STIMULATION OF THE PHOSPHOINOSITIDE SIGNALING SYSTEM IN VASCULAR SMOOTH-MUSCLE CELLS [J].
KO, Y ;
GORG, A ;
APPENHEIMER, M ;
WIECZOREK, AJ ;
DUSING, R ;
VETTER, H ;
SACHINIDIS, A .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1992, 227 (02) :215-219
[6]   EFFECTS OF AN ANGIOTENSIN-II RECEPTOR ANTAGONIST, CV-11974, ON ANGIOTENSIN-II-INDUCED INCREASES IN CYTOSOLIC-FREE CALCIUM-CONCENTRATION, HYPERPLASIA, AND HYPERTROPHY OF CULTURED VASCULAR SMOOTH-MUSCLE CELLS [J].
KOH, E ;
MORIMOTO, S ;
TOMITA, J ;
RAKUGI, H ;
JIANG, BB ;
INOUE, T ;
NABATA, T ;
FUKUO, K ;
OGIHARA, T .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 23 (02) :175-179
[7]  
NODA M, 1993, BIOCHEM PHARMACOL, V46, P311
[9]   EXP3174, A METABOLITE OF LOSARTAN (MK-954, DUP-753) IS MORE POTENT THAN LOSARTAN IN BLOCKING THE ANGIOTENSIN-II-INDUCED RESPONSES IN VASCULAR SMOOTH-MUSCLE CELLS [J].
SACHINIDIS, A ;
KO, Y ;
WEISSER, P ;
BRICKWEDDE, MKMZ ;
DUSING, R ;
CHRISTIAN, R ;
WIECZOREK, AJ ;
VETTER, H .
JOURNAL OF HYPERTENSION, 1993, 11 (02) :155-162
[10]  
SCHELLING P, 1991, J HYPERTENS, V9, P3